MedTrace Logo

A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks

NCT02720991 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-03-28

No results posted yet for this study

Summary

A pilot study on the acceptability and feasibility with Mifepristone and 400 mg of sub-lingual Misoprostol between 71-77 and 78-84 days of gestation for 50 cases.

Conditions

  • Abortion, 3 Months

Interventions

DRUG

Mifepristone

200 mg of oral mifepristone

DRUG

Sublingual misoprostol

400 ug of misoprostol sublingually following mifepristone

Sponsors & Collaborators

  • Hopital La Rabta

    collaborator OTHER

  • Gynuity Health Projects

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-04-30
Completion
2015-04-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02720991 on ClinicalTrials.gov